Q32 Bio Inc.QTTBNASDAQ

Revenue (LTM)

$54M

Net Income (LTM)

$30M

+162.5% YoY

Free Cash Flow

$-24M

Revenue CAGR (5Y)

+81.9%

Marginsimproving

FCF($0.0B)

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	34	7↓80.4%	-7↓200.0%	0	54
Gross Profit	24	7↓72.8%	-7↓200.0%	-0↑92.7%	53↑11054.0%
Operating Income	-96	-39↑59.1%	-48↓23.0%	-66↓37.0%	17↑125.6%
Net Income	-96	-43↑55.3%	-54↓25.5%	-48↑11.2%	30↑162.5%
EBITDA	-86	-39↑54.9%	-48↓22.9%	-45↑5.1%	17↑138.2%
EPS Diluted	-31.18	-13.42↑57.0%	-16.70↓24.4%	-6.58↑60.6%	2.42↑136.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	108	44↓59.5%	26↓41.6%	78↑204.3%	48↓38.1%
Total Current Assets	192	47↓75.6%	29↓38.7%	82↑185.1%	55↓32.8%
Total Assets	212	62↓70.8%	47↓23.8%	92↑96.2%	62↓33.1%
Total Current Liabilities	17	58↑235.9%	14↓75.6%	16↑16.7%	11↓31.1%
Total Liabilities	42	192↑357.5%	230↑19.5%	87↓62.3%	20↓77.2%
Total Equity	170	178↑4.9%	-183↓202.8%	6↑103.1%	42↑640.3%
Total Debt	24	45↑86.9%	51↑13.7%	19↓62.8%	15↓18.8%
Net Debt	-84	1↑101.0%	25↑2909.9%	-59↓334.2%	-33↑44.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-110	-11↑90.0%	-19↓70.5%	-68↓262.6%	-34↑50.5%
Capital Expenditure	-2	-2↓3.7%	-0↑99.8%	-0↓1400.0%	0↑102.7%
Free Cash Flow	-112	-13↑88.0%	-19↓39.0%	-68↓262.9%	-24↑64.3%
Stock-Based Comp	0	1	1↑15.3%	4↑207.1%	3↓38.4%
Net Change in Cash	-109	17↑115.3%	-8↓150.3%	47↑665.8%	-30↓162.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance